[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100386670":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":19,"studyPopulation":20,"armGroups":16,"interventions":16,"overallOfficials":21,"centralContacts":28,"locations":37,"responsibleParty":56,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":16,"enrollmentInfo":71,"targetDuration":74,"studyType":75,"phases":16,"briefSummary":76,"conditions":77,"keywords":16,"overallStatus":40,"whyStopped":16,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University of California, Davis","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":16,"otherOutcomes":16},[9,13],{"measure":10,"description":11,"timeFrame":12},"Review the response rate of mailed out surveys, compared by race\u002Fethnicity and disease status","Response Rate in percentage","2025",{"measure":14,"description":15,"timeFrame":12},"Response rate for saliva kits compared to survey response and determine if there is a disparity in participation between race\u002Fethnic groups","Response Rates in percentage",null,{"allocation":16,"interventionModel":16,"interventionModelDescription":16,"primaryPurpose":16,"observationalModel":18,"timePerspective":6,"maskingInfo":16},"CASE_CONTROL","Eligible patients will include AAs, Latinos and AANHPIs who were diagnosed with a first primary, pathologically confirmed MM within the previous five years and who were at least 21 years of age at the time of diagnosis. We will also include, as a comparison group, non-Hispanic White patients. Patients must have been diagnosed in one of counties of California. Patients must be alive at the time of study and able to provide informed consent. We will not include those who are unable to consent, pregnant women, or prisoners.\n\nInitially, in the pilot phase, we randomly selected 100 eligible patients from each race\u002Fethnicity mentioned above to participate in the pilot study. As the pilot has been completed, we now aim to contact at recruit 1,000 patients per race\u002Fethnic group reported to all three population cancer registries in the state, including the Greater Bay Area Cancer Registry and the Los Angeles Cancer Surveillance Program and Cancer Registry of Greater California until 2025. Patients diagnosis dates for the next phase of the study (June 2021-May 2025) will include diagnosis dates from 2018-2023, as there is a 2 year lag between patients cancer diagnosis and cancer registries information recorded.\n\nDrs. Carvajal-Carmona and Cress have coordinated with MEDULLA investigators and CRGC research staff to develop a questionnaire for racial\u002Fethnic minorities with Multiple Myeloma. The survey focuses on demographics, risk factors, cancer treatment, quality of life, and social determinants of health. All survey items are adapted from previously tested and validated surveys. The survey is expected to take approximately 30-45 minutes to complete.\n\nCRGC staff, under Dr. Cress supervision, will identify eligible participants using the criteria described above based on diagnostic information in the CRGC database. The research team will be following California Cancer Registry policies and procedures for release of data. CRGC staff will extract patients contact information from the registry and will provide this information to research staff at UC Davis, who will work under Dr. Carvajal-Carmona's supervision.\n\nThe UC Davis Research team will initially mail each eligible participants a postcard and a survey study packet that will include: 1) Simple instruction sheet 2) An introductory letter that details the study 3) Information sheet that details on informed consent 4) Survey instruction sheet 5) A paper copy of the survey 5) Incentive selection sheet and option to continue to the second part of study 6) Brochures about the cancer registry and the UC Davis Comprehensive Cancer Center, and return pre-paid envelope.","We will recruit 4,000 participants (1000 Latinos\u002F 1000 African Americans\u002F 1000 Asian American\u002FNative Hawaiian\u002FPacific Islanders\u002F 1000 Non-Hispanic Whites). Participants will be randomly selected from cancer registry using the criteria above.",[22,25],{"name":23,"affiliation":5,"role":24},"Luis Carvajal-Carmona, PhD","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":27,"role":24},"Rosemary Cress, DrPh MPH","Cancer Registry of California",[29,33],{"name":23,"role":30,"phone":31,"phoneExt":16,"email":32},"CONTACT","5307529654","lgcarvajal@ucdavis.edu",{"name":34,"role":30,"phone":35,"phoneExt":16,"email":36},"Angelica Perez, BS","9167344563","amiperez@ucdavis.edu",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"University of California Davis Comprehensive Cancer Center","RECRUITING","Sacramento","California","95817","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-121.4944,38.58157,{"lat":50,"lon":49},[53,55],{"name":23,"role":30,"phone":54,"phoneExt":16,"email":32},"530-752-9654",{"name":34,"role":30,"phone":35,"phoneExt":16,"email":36},{"type":57,"investigatorFullName":16,"investigatorTitle":16,"investigatorAffiliation":16,"oldNameTitle":16,"oldOrganization":16},"SPONSOR",[59],{"name":60,"class":61},"Cancer Registry of Greater California","UNKNOWN","100386670","development-of-a-research-infrastructure-for-understanding-and-addressing-multiple-myeloma-disparities-100386670",false,"NCT04314752","Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities","MEDULLA","Inclusion Criteria:\n\n* Diagnosed with a first primary pathologically confirmed case of Multiple Myeloma within the previous 5 years\n* At least 21 years of age at the time of diagnosis\n* Must have been diagnosed in one of the 48 counties in California\n* Participant must be alive\n* Identify as one of the following: African American, Latino, Asian American\u002FNative Hawaiian\u002FPacific Islander, Non-Hispanic White\n\nExclusion Criteria:\n\n* People who have not been diagnosed with Multiple Myeloma\n* Under the age of 21\n* Pregnant\n* Prisoner","ALL","21 Years",{"count":72,"type":73},4000,"ESTIMATED","5 Years","OBSERVATIONAL","The objectives of the proposed study are to develop and evaluate protocols for ethnic\u002Fracial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater California (CRGC), the investigators have developed procedures to identify, recruit, and survey ethnic\u002Fracial minority patients with MM. To pilot the study, the investigators aim initially to test the feasibility of this protocol by contacting 400 eligible patients (100 African Americans, 100 Latinos, 100 Asian American\u002FNative Hawaiian\u002FPacific Islander-AANHPI and 100 non-Hispanic Whites as a comparison group) to conduct a pilot survey through which will ascertain etiological and survival-related factors for MM. Ultimately, the investigators hope the findings from this pilot will yield insight into the best practices for recruiting minorities with MM and serve as the basis for larger population-based studies of MM etiology and survival.\n\nThe next phase of this study is to expand the study to all 3 California Cancer Registries, including the Greater Bay Area Cancer Registry and the Los Angeles Cancer Surveillance Program and Cancer Registry of Greater California. We will increase the sample size to recruit atleast 1000 participants per racial\u002Fethnic group. We will also request to increase the scope of the study to also continue a survivorship cohort.",[78],"Multiple Myeloma","2026-09-09",{"date":81,"type":82},"2026-09-14","ACTUAL",{"date":84,"type":82},"2020-09-01",{"date":86,"type":73},"2026-12-30",{"name":5,"class":6},1]